We are live on ! Find out more
Caption Management

Caption Management Portfolio holdings

AUM $21.5B Turnover 58.11%
1-Year Est. Return 81.81%
 

Caption Management runs private funds that trade U.S. stocks and stock options, usually holding positions for two to four months. It looks for mispricings in stock and options markets through company research, and aims to profit from moves in share prices or in expected price swings. Jason Strasser and William Cooper, who both graduated from Duke University in 2007, started the firm in 2012 and own most of it. Strasser began his career as an equity derivatives trader at Morgan Stanley and then worked as an analyst at the hedge fund Trafelet & Company. Its funds are open to high net worth individuals, family offices, endowments, foundations and institutional investors.

This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$21.5B
AUM Growth
+$4.34B
Cap. Flow
+$423M
Cap. Flow %
1.97%
Top 10 Hldgs %
19.17%
Holding
2,170
New
686
Increased
353
Reduced
351
Closed
575
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.42%
2 Technology 5.01%
3 Healthcare 1.9%
4 Consumer Discretionary 1.75%
5 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MP icon
551
PUT
MP Materials
MP
$6.4B
$5.6M 0.03%
100,000
– –
2025 Q1
5 quarters
IBB icon
552
CALL
iShares Biotechnology ETF
IBB
$11.7B
$5.55M 0.03%
+29,200
New +$5.02M
2026 Q2
0 quarters
WBI icon
553
CALL
WaterBridge Infrastructure LLC
WBI
$1.57B
$5.55M 0.03%
+162,000
New +$4.72M
2026 Q2
0 quarters
PTGX icon
554
Protagonist Therapeutics
PTGX
$9.28B
$5.52M 0.03%
+45,000
New +$4.7M
2026 Q2
0 quarters
IMCR icon
555
PUT
Immunocore
IMCR
$1.55B
$5.5M 0.03%
173,100
-1,069,400
-86% -$31.6M
2025 Q1
5 quarters
MTZ icon
556
MasTec
MTZ
$13.5B
$5.49M 0.03%
+13,200
New +$5.05M
2026 Q2
0 quarters
GMAB icon
557
Genmab
GMAB
$33.9B
$5.49M 0.03%
+199,774
New +$5.31M
2026 Q2
0 quarters
IMCR icon
558
Immunocore
IMCR
$1.55B
$5.48M 0.03%
172,503
-489,283
-74% -$14.5M
2025 Q1
5 quarters
DPZ icon
559
Domino's
DPZ
$11.2B
$5.44M 0.03%
+18,371
New +$6.05M
2026 Q2
0 quarters
BAP icon
560
CALL
Credicorp
BAP
$27.9B
$5.42M 0.03%
+13,900
New +$4.75M
2026 Q2
0 quarters
BAP icon
561
PUT
Credicorp
BAP
$27.9B
$5.42M 0.03%
+13,900
New +$4.75M
2026 Q2
0 quarters
OKTA icon
562
PUT
Okta
OKTA
$33.4B
$5.4M 0.03%
+39,600
New +$3.72M
2026 Q2
0 quarters
CRBP icon
563
CALL
Corbus Pharmaceuticals
CRBP
$69M
$5.37M 0.03%
+572,300
New +$5.42M
2026 Q2
0 quarters
SKE icon
564
PUT
Skeena Resources
SKE
$3.68B
$5.33M 0.02%
+200,000
New +$6.01M
2026 Q2
0 quarters
XLE icon
565
State Street Energy Select Sector SPDR ETF
XLE
$41.8B
$5.29M 0.02%
99,516
+76,400
+331% +$4.37M
2026 Q1
1 quarter
CELC icon
566
CALL
Celcuity
CELC
$3.39B
$5.23M 0.02%
50,000
-550,000
-92% -$63.5M
2025 Q3
3 quarters
RSI icon
567
Rush Street Interactive
RSI
$1.44B
$5.22M 0.02%
+175,461
New +$4.62M
2026 Q2
0 quarters
FTRE icon
568
CALL
Fortrea Holdings
FTRE
$2.02B
$5.21M 0.02%
299,500
-599,500
-67% -$8.09M
2026 Q1
1 quarter
PRGO icon
569
CALL
Perrigo
PRGO
$2.2B
$5.2M 0.02%
+500,000
New +$5.5M
2026 Q2
0 quarters
PRGO icon
570
PUT
Perrigo
PRGO
$2.2B
$5.2M 0.02%
+500,000
New +$5.5M
2026 Q2
0 quarters
ILMN icon
571
CALL
Illumina
ILMN
$34.3B
$5.19M 0.02%
+29,500
New +$4.32M
2026 Q2
0 quarters
ZM icon
572
CALL
Zoom
ZM
$26.8B
$5.18M 0.02%
60,000
-12,800
-18% -$1.21M
2026 Q1
1 quarter
MOH icon
573
PUT
Molina Healthcare
MOH
$11.8B
$5.15M 0.02%
22,500
-55,500
-71% -$10.1M
2026 Q1
1 quarter
KTOS icon
574
CALL
Kratos Defense & Security Solutions
KTOS
$6.77B
$5.14M 0.02%
103,000
-6,000
-6% -$363K
2025 Q3
3 quarters
PGEN icon
575
Precigen
PGEN
$1.81B
$5.13M 0.02%
900,000
+593,384
+194% +$2.56M
2026 Q1
1 quarter

Similar funds

Caption Management's Q2 2026 Portfolio in Review

As of Q2 2026, Caption Management held 2,170 positions worth $21.5B, up 25% from $17.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Caption Management's Q2 2026 filing shows 686 new, 353 increased, 351 reduced and 575 closed positions. Its largest new stake was TSMC: 565,700 shares worth $270M. The largest sale was Meta Platforms (Facebook), an estimated $52.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q2 2026 buy was TSMC: 565,700 shares worth $270M.
  • Caption Management added most to Microsoft in Q2 2026, an estimated $198M increase.
  • Caption Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $52.2M.
  • Caption Management fully exited Planet Labs PBC Warrants in Q2 2026, selling an estimated $24.9M.
  • Caption Management's ten largest holdings make up 19% of its $21.5B portfolio in Q2 2026.
  • Caption Management opened 686 new positions and closed 575 in Q2 2026.
  • Caption Management's portfolio value rose 25% quarter-over-quarter to $21.5B.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.